
March Medicaid Madness
KFF Health News' 'What the Health?'
Do Exceptions Work or Are They a Good Idea?
This week elia lily announced it would lower in some cases dramatically the list prices for some of its insulin products. A drug pricing expert at west health policy center shondixon pointed out that there's a new kind of policy going into effective medicaid next year. There is definitely a possibility for some ulterior motives here and i hadn't known this before but the three big insulin makers which are lily, sanofi and nordis may become almost the only insulin maker left.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.